Related Experiment Video

Updated: Apr 14, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

9.7K

Resident rounds Part III: Metastatic melanoma patient on vemurafenib develops multiple primary cutaneous melanomas

Jeffrey Brackeen, Jordan Jamerson, Amy Brackeen

    Journal of Drugs in Dermatology : JDD
    |April 25, 2015
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    A Melanoma Patient-Derived Xenograft Model
    07:07

    A Melanoma Patient-Derived Xenograft Model

    Published on: May 20, 2019

    13.4K
    A 3D Organotypic Melanoma Spheroid Skin Model
    08:49

    A 3D Organotypic Melanoma Spheroid Skin Model

    Published on: May 18, 2018

    16.8K

    Related Experiment Videos

    Last Updated: Apr 14, 2026

    Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
    06:09

    Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

    Published on: June 7, 2019

    9.7K
    A Melanoma Patient-Derived Xenograft Model
    07:07

    A Melanoma Patient-Derived Xenograft Model

    Published on: May 20, 2019

    13.4K
    A 3D Organotypic Melanoma Spheroid Skin Model
    08:49

    A 3D Organotypic Melanoma Spheroid Skin Model

    Published on: May 18, 2018

    16.8K

    Related Concept Videos

    Skin Cancer01:30

    Skin Cancer

    6.6K
    Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
    Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
    6.6K
    Treatment Resistant Cancers02:56

    Treatment Resistant Cancers

    3.9K
    Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
    3.9K
    Treatment Resistent Cancers02:56

    Treatment Resistent Cancers

    1.5K
    1.5K

    Articles linked to this work by shared authors, journal, and citation graph.

    Erythema multiforme after treatment with sorafenib.

    Proceedings (Baylor University. Medical Center)·2021

    A case of S-100-negative CD1a-positive indeterminate cell histiocytosis.

    Journal of cutaneous pathology·2019

    Clinical impact of a 31-gene expression profile test for cutaneous melanoma in 156 prospectively and consecutively tested patients.

    Current medical research and opinion·2016

    Plasma cell granuloma: a case report of multiple lesions in the lung and review of the literature.

    The American journal of the medical sciences·2007

    Pigmentary changes and atopic dermatitis in a patient with Seckel syndrome.

    Pediatric dermatology·2007

    Red Light Therapy in Cosmetic Dermatology: Marketing Claims Backed by Evidence?

    Journal of drugs in dermatology : JDD·2026

    : Interleukin-31 in Atopic Dermatitis and Prurigo Nodularis: Pathophysiology, Neuroimmune Mechanisms, and Clinical Efficacy of Nemolizumab.

    Journal of drugs in dermatology : JDD·2026

    : Real-World Cases Using Phyto Polydeoxyribonucleotide (PDRN) Serum.

    Journal of drugs in dermatology : JDD·2026

    Topical Carboxytherapy as an Adjunct to Skin Recovery Post-CO2 Laser Fractional Resurfacing.

    Journal of drugs in dermatology : JDD·2026

    Clinical Evidence of Skin Improvements With a Biologically Active Multimodal Topical Skin Treatment.

    Journal of drugs in dermatology : JDD·2026

    Safety and Tolerability of Facial Skincare in Children and Adolescents: Clinical Testing and Multigenerational Insights.

    Journal of drugs in dermatology : JDD·2026

    Health care access, affordability, and satisfaction following enrollment in Medicare Advantage.

    Health affairs scholar·2026

    Rapid glycolytic metabolism underpins mucosal-associated invariant T cell functional responses to innate cytokines.

    Journal of immunology (Baltimore, Md. : 1950)·2026

    RAVEN: Robust, generalizable, multi-resolution structural MRI upsampling using autoencoders.

    Imaging neuroscience (Cambridge, Mass.)·2026

    MA Dental Plan Enrollment And Generosity Increased, But Continuity Of Coverage Declined, 2010-25.

    Health affairs (Project Hope)·2026

    Aerobiology and Transmission of Mycobacterium tuberculosis.

    Cold Spring Harbor perspectives in medicine·2026

    Advancing the measurement of favorable selection in Medicare Advantage: evidence from encounter data.

    Health affairs scholar·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us